Tuberculosis Elimination, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
|
|
- Milton Thomas
- 6 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE /j x Association of specific mutations in katg, rpob, rpsl and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia M. Y. Lipin 1, V. N. Stepanshina 1, I. G. Shemyakin 1 and T. M. Shinnick 2 1 State Research Center for Applied Microbiology, Obolensk, Moscow Region, Russia and 2 Division of Tuberculosis Elimination, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA ABSTRACT Most multidrug-resistant (MDR) Mycobacterium tuberculosis isolates in Russia belong to the Beijing or Latino-American and Mediterranean (LAM) spoligotype families. The objective of this study was to investigate possible associations between genotype and the frequencies of mutations that confer drug resistance in a population that has two large families of circulating strains. Spoligotyping, IS6110 restriction fragment length polymorphism typing, and sequencing of the katg and rpob genes, were performed for 217 consecutive MDR M. tuberculosis isolates from patients. The rpsl and rrs genes were also sequenced for selected streptomycin-resistant isolates. Of the 217 MDR isolates, 99 (46%) belonged to the LAM family, 92 (42%) to the Beijing family, 21 (10%) to the Haarlem family and four (2%) to the T family. There was one unique spoligotype. Mutations in the katg gene were identified in 207 (95%) isolates, all of which had mutations in codon 315. Mutations in the rpob gene were identified in 200 (92%) isolates; 75% of LAM isolates carried a mutation in codon 516, whereas 71% of Beijing isolates carried a mutation in codon 531. In the 33 isolates resistant to streptomycin 50 mg L, the 43AGG rpsl mutation was found in 27% of Haarlem, 75% of Beijing and 0% of LAM isolates, and rrs mutations were found in 17% (516C fi T) of Beijing and 100% (513A fi C) of LAM isolates. Overall, there appeared to be a correlation between the genotype and specific mutations conferring resistance to rifampicin or streptomycin in the Beijing and LAM families. The biological implications of this correlation remain to be explored. Keywords Genotype, multidrug resistance, mutations, Mycobacterium tuberculosis, resistance, spoligotype Original Submission: 21 July 2006; Revised Submission: 12 December 2006; Accepted: 27 December 2006 Clin Microbiol Infect 2007; 13: INTRODUCTION Tuberculosis (TB) is an urgent public health problem in both industrialised and developing countries. Efforts to control TB have recently been complicated by the worldwide spread of multidrug-resistant (MDR; resistant to at least isoniazid and rifampicin) strains of Mycobacterium tuberculosis [1]. In several regions of the world, the spread of MDR TB has been associated with the expansion of strains belonging to the Beijing family [2]. Drug resistance results from the Corresponding author and reprint requests: T. Shinnick, Centers for Disease Control and Prevention, Mailstop G35, 1600 Clifton Road, Atlanta GA 30333, USA tms1@cdc.gov accumulation of chromosomal mutations, in part because tubercle bacilli have no known efficient mechanism for horizontal gene transfer [3]. Despite the need for several independent mutations, resistance to multiple drugs is not uncommon, as successive rounds of inadequate or inappropriate therapy, or incomplete compliance, can lead to the stepwise accumulation of drug resistance mutations [1]. In the mycobacteria, rifampicin resistance is associated with changes in the rpob gene, and isoniazid resistance is associated primarily with changes in the katg, inha or aphc genes [4 7]. Genotyping of M. tuberculosis isolates has proven to be a powerful approach for investigating transmission dynamics, circulating strains, and the natural history of TB. The commonly used Ó 2007 Copyright by the European Society of Clinical Microbiology and Infectious Diseases
2 Lipin et al. TB drug resistance mutations and spoligotypes 621 genotyping methods are spoligotyping, IS6110 restriction fragment length polymorphism (RFLP) typing, and mycobacterial interspersed repetitive unit typing [8 10]. Families of M. tuberculosis isolates are defined on the basis of shared spoligotypes or closely related IS6110 RFLP patterns. The distribution of M. tuberculosis genotype families varies greatly by region [11,12]. In Russia, the majority of M. tuberculosis isolates belong to either the Beijing or Latino-American and Mediterranean (LAM) families [13 17]. Because genotyping techniques measure variations in the M. tuberculosis genome unrelated to the acquisition of drug resistance, it was somewhat surprising to find that certain mutations appear to predominate in drug-resistant members of some families. For example, the katg 315 mutation appears to predominate in isoniazidresistant isolates of the Beijing family [7,17,18]. The objective of the present study was to take advantage of the presence of two large families of strains in Russia to investigate correlations between specific drug resistance mutations and the genotype of MDR strains of M. tuberculosis. MATERIALS AND METHODS Patients In total, 312 consecutive M. tuberculosis isolates resistant to at least one anti-tb drug were obtained from 312 pulmonary TB patients in two neighbouring regions, Tula and Serpukhov District of Moscow, between 1998 and Of these patients, 241 (77.2%) were chronic cases, 285 (91.3%) were male, and none was infected with human immunodeficiency virus; the mean age was 43 years. Resistance to both isoniazid and rifampicin was detected in isolates from 217 patients (of whom 93.1% were chronic cases and 92.2% were male). Only the 217 MDR isolates were included in this study. Drug susceptibility testing Isolates were tested for susceptibility to isoniazid, streptomycin, rifampicin, kanamycin and ethambutol, using the absolute concentration method on Loewenstein Jensen medium [19]. The concentrations of the drugs used in the medium were: for isoniazid, 1, 5 and 25 mg L; for streptomycin, 5, 10 and 50 mg L; for rifampicin, 20 and 50 mg L; for kanamycin, 30 and 50 mg L; and for ethambutol, 2 and 5 mg L. Isolates that grew on the lowest concentration of the drug tested were considered to be resistant to that drug. Genotyping Spoligotyping was performed as described previously [8], using membranes made at the CDC. IS6110 RFLP typing of M. tuberculosis isolates was carried out as described previously [9]. IS6110 RFLP images on films were scanned (200 dpi, 256 grayscales) and processed with GelCompar II v.2.5 (Applied Maths, Sint-Martens-Latem, Belgium) software. Sets of restriction fragments were considered as vectors in multidimensional Euclid space [15] and processed with the unweighted pairgroup method using arithmetic averages (Jaccard s similarity coefficient, tolerance 1.0%, optimisation 0.7%). DNA sequencing DNA samples were prepared as described previously [9]. Primers for PCR amplification and sequencing are listed in Table 1. The primers were selected to amplify and sequence the rifampicin resistance-determining region (RRDR) of the rpob gene (bases ; Escherichia coli numbering system), 697 bp of the katg gene, including the region around codon 315 (bases ), the entire katg gene (bases )23 to +2232), 248 bp and 283 bp of the inha (bases )168 to +79) and ahpc (bases )182 to +100) regulatory regions, 373 bp of the rpsl gene, including the region around codon 43 (bases ), and 553 bp of the rrs gene, including the region around nucleotide 530 (bases ). The amplification mixture consisted of PCR buffer containing 2.5 mm MgCl 2 (Fermentas, Vilnius, Lithuania), DNA 0.2 ng ll, 0.15 mm each dntp (Fermentas), 0.4 lm forward and reverse primers (Syntol, Moscow, Russia), and 0.05 U ll Taq DNA polymerase (Fermentas). Thermocycling conditions comprised 95 C for 4 min, 25 cycles of 30 s at 95 C, 30 s at Table 1. Primers used for PCR amplification and sequencing Gene Forward primer, 5 )3 Reverse primer, 5 )3 katg fragment (217 isolates) CTCCGCTGGAGCAGATGGGC TCTTCCAGGGTGCGAATGACCT katg full (four isolates) CACCAACTCCTGGAAGGAATGC CATCTGCTCCAGCGGAGCAG CGGTCACACTTTCGGTAAGACC CCACCGAGCACGACGAGGTC CATTCGCACCCTGGAAGAGATC CAACCCGAATCAGCGCACGTC inha Amplification (regulatory region) CCTCGCTGCCCAGAAAGGGA ATCCCCCGGTTTCCTCCGGT ahpc Amplification (regulatory region) CCGCAACGTCGACTGGCTCA CGATGAGAGCGGTGAGCTGG rpsl Amplification CCAGCAGCTGGTCCGCAAGG TGCGTGGCATCAGCCCTTCTC 16S rrna TAAACCTCTTTCACCATCGACGA CCAGGTAAGGTTCTTCGCGTTG rpob GTCGGCGAGCTGATCCAAAAC GGTACGGCGTTTCGATGAACC
3 622 Clinical Microbiology and Infection, Volume 13 Number 6, June C and 60 s at 72 C, followed by 30 s at 57 C, 5 min at 72 C, and cooling to 10 C. Amplicons were purified by electrophoresis on agarose 1% w v gels, followed by recovery with a DNA extraction kit (Fermentas). was performed using the Thermo Sequenase Radiolabelled Terminator Cycle kit (Fermentas) according to Sanger et al. [20], with a thermocycling profile of 94 C for 3 min, 25 cycles of 30 s at 94 C, 30 s at 57 C and 60 s at 72 C, followed by 30 s at 57 C, 5 min at 72 C, and cooling to 10 C. Sequences were compared to those of the wild-type (WT) genes of strain H37Rv ( Statistical methods CIs (95%) and the probability, p, that a difference between mean values is casual, were estimated using binomial distribution. RESULTS The spoligotyping analysis identified four (1.8%) T family, 21 (9.7%) Haarlem family, 92 (42.4%) Beijing family and 99 (45.6%) LAM family isolates. The spoligotype of one isolate did not belong to a known family. IS6110 RFLP typing revealed 94 (43.3%) different strains with unique profiles, comprising 33 LAM, 37 Beijing, 19 Haarlem and four T family strains. The results of IS6110 RFLP typing were used to select isolates for sequencing (rpsl, rrs, inha and ahpc genes) in order to avoid sequencing multiple isolates of the same strain. In addition to being resistant to isoniazid and rifampicin, all 217 MDR isolates were resistant to streptomycin, 150 (69%) were resistant to kanamycin, and 178 (82%) were resistant to ethambutol. The frequency of kanamycin-resistant isolates was greater in the LAM family than in the Beijing and Haarlem families (83%, 60% and 38%, respectively; p <0.0003). There was no significant difference in the frequency of ethambutol-resistant isolates among the LAM, Beijing, Haarlem and T families. Mutations in the katg gene were identified in 207 (95.4%) of the 217 MDR isolates, including 99% of the MDR isolates in the LAM family (codon 315ACC, n = 97; 315AGA, n = 1), 57% of the MDR isolates in the Haarlem family (315ACC, n = 12), and all of the MDR isolates in the Beijing (315ACC, n = 91; 315AGA and 335GTC, n = 1) and T families (315ACC, n = 4). All Beijing family isolates also carried the codon 463CTG polymorphism. However, this polymorphism is not associated with isoniazid resistance [21], but is one of the genetic polymorphisms used to identify the principal genotypic groups of M. tuberculosis isolates [3]. The frequency of isoniazid-resistant isolates with a WT katg gene in the region sequenced (697 bp) was greater in the Haarlem family than in the LAM and Beijing families (43%, 1%, and 0%, respectively; p <0.001). The isoniazid-resistant isolate with the unclassified spoligotype had mutations in codons 315ACC and 463CTG of the katg gene. The frequency of isoniazid-resistant isolates that carried a mutation in katg codon 315 and were resistant to the high (25 mg L) concentration of isoniazid was greater in the LAM family (n = 47, 48%) than in the Beijing (n = 8, 8.7%; p <0.001) and Haarlem (n =2,17%; p <0.04) families (Fig. 1). In order to investigate the high isoniazid resistance of some isolates carrying the codon 315 katg mutation, the regulatory regions of two other genes (inha and ahpc) known to influence isoniazid resistance were sequenced in isolates that carried a codon 315 mutation and did not belong to the same IS6110 RFLP cluster. None of the isolates of any family had more than one mutation in the regulatory sequences of the inha and ahpc genes. A mutation in the regulatory region of the ahpc gene ()30C fi T) was detected in one of the eight Beijing family isolates resistant to isoniazid 25 mg L. Mutations in the regulatory region of the inha gene ()15C fi T) were detected in three of the eight Beijing family isolates resistant to isoniazid 25 mg L, in two of the nine Beijing family isolates resistant to isoniazid 1mg L, in all 14 LAM family isolates resistant to isoniazid 25 mg L, in nine of the ten LAM family isolates resistant to isoniazid 1 mg L, in neither of two Haarlem family isolates resistant to isoniazid 25 mg L, and in two of four Haarlem family isolates resistant to isoniazid 1 mg L. The difference between the frequencies of this mg/l 5 mg/l 25 mg/l Beijing Haarlem LAM Fig. 1. Level of resistance to isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates belonging to different families.
4 Lipin et al. TB drug resistance mutations and spoligotypes 623 mutation in isolates resistant to isoniazid 25 mg L and those resistant to isoniazid 1 mg L in any family was not significant (p 0.4). In order to determine the molecular basis for resistance to the high concentration of streptomycin, the rpsl and rrs (16S rrna) genes were sequenced in selected isolates that did not belong to the same IS6110 RFLP cluster and had resistance to streptomycin 50 mg L. The 513A fi C mutation in the rrs gene was detected in all ten LAM family isolates tested. The codon 43AAG fi AGG mutation was detected in the rpsl gene of three (27%) of 11 Haarlem family isolates tested, and in nine (75%) of 12 Beijing family isolates tested, while the 516C fi T mutation in the rrs gene was detected in two (17%) Beijing family isolates (Fig. 2). The frequency (73%) of streptomycin-resistant (50 mg L) isolates with mutations in neither the rpsl nor the rrs genes in the Haarlem family was greater than that in the LAM (0%, p <0.001) or Beijing (8%, p <0.001) families. The rpsl and rrs genes were also sequenced in five Beijing family isolates showing resistance to streptomycin 10 mg L and susceptibility to streptomycin 50 mg L; the 43AAG fi AGG mutation in the rpsl gene was detected in one (20%) isolate, and the 516C fi T mutation in the rrs gene was detected in four (80%) isolates. The frequency of the 43AAG fi AGG mutation in the Beijing family isolates with resistance to streptomycin 50 mg L was greater than that in isolates with resistance only to streptomycin 10 mg L (75% vs. 20%; p 0.06). Mutations in the RRDR of the rpob gene were identified in 200 (92%) of the 217 MDR isolates. The most frequent mutations were substitutions in codons 516, 526 or 531 of the rpob gene, which were found in 194 (89%) of the 217 isolates. The mutations in the rpob gene of the 92 MDR isolates of the Beijing family were 511CCG (n = 2), 513CCA (n = 1), deletion CAT (n = 1), 516GTC (n = 3), 516TAC (n = 2), 522TTG (n = 1), 525ACG + 526TAC + 527CAG (n = 1), 526CGC (n = 1), 526CTC (n = 1), 526GAC (n = 6), 526TAC (n = 5), 531TGG (n = 1), 531TTG (n = 64) and 533CCG (n = 1); two isolates had no mutations in the RRDR of the rpob gene. Mutations in codon 531 of the rpob gene were detected in 65 (71%) of 92 MDR isolates of the Beijing family. The rpob mutations in the 99 MDR isolates of the LAM family were 516GTC (n = 73), 516TAC (n = 1), 522CAG (n = 1), 526CTC (n = 1), 526GAC (n = 11), 526TAC (n = 1) and 531TTG (n = 7); four isolates had no mutations in the RRDR of the rpob gene. Mutations in codon 516 of the rpob gene were detected in 74 of the 99 MDR isolates of the LAM family. The rpob mutations in the 21 MDR isolates of the Haarlem family were 516GTC (n = 1), 516TAC (n = 1), 526GAC (n = 2), 526TAC (n = 2), 531TTG (n = 4) and 533CCG (n = 1); ten isolates had no mutations in the RRDR of the rpob gene. The frequency (48%) of MDR isolates in the Haarlem family with a WT rpob gene was greater than that in the LAM (4%, p <0.001) or Beijing (2%, p <0.001) families (Fig. 3). The rpob mutations in the four MDR isolates of the T family were 516GTC (n = 2), 526GAC (n = 1) and 526TAC (n = 1). The MDR isolate with the unclassified spoligotype had a WT rpob gene. Isolates in the same IS6110 RFLP cluster often had different mutations in the rpob gene. For example, the correlation coefficient between the Fig. 2. Mutations in the rpsl and 16S rrna genes of streptomycin-resistant (50 mg L) Mycobacterium tuberculosis isolates belonging to different families (WT, wild-type). Fig. 3. Mutations in the rpob gene in rifampicin-resistant Mycobacterium tuberculosis isolates belonging to different families (WT, wild-type).
5 624 Clinical Microbiology and Infection, Volume 13 Number 6, June 2007 presence of the mutation 531TTG and the affiliation of an isolate with the largest IS6110 RFLP cluster (n = 35) of the Beijing family was A correlation between the position of a mutation in the rpob gene and the affiliation of an isolate with a particular IS6110 RFLP cluster was detected for only one cluster containing 43 isolates of the LAM family (p 0.51), but affiliation of an isolate with this cluster and the level of rifampicin resistance were not correlated (p 0.02). Of the 217 MDR isolates, ten carried no mutations in the sequenced region of the katg gene, 17 carried no mutations in the RRDR of the rpob gene, and eight carried no mutations in the sequenced regions of both the katg and rpob genes. One of these eight isolates belonged to the LAM family and produced 20 colonies on Loewenstein Jensen medium containing rifampicin 20 mg L, which was the minimum number required to consider an isolate as rifampicin-resistant; the other seven isolates belonged to the Haarlem family. Regulatory regions of the inha and ahpc genes were sequenced for these eight MDR isolates, and all eight had a WT regulatory sequence for the inha gene. Three isolates of the Haarlem family had either the )6G fi A, )10C fi T or )32G fi A mutations in the regulatory sequence of the ahpc gene. As mutations in this regulatory region often coincide with deletions in the katg gene, the entire katg sequence of these isolates was determined, revealing that each isolate had a WT katg sequence. DISCUSSION Beijing family strains of M. tuberculosis are prevalent in many regions of the world and are often associated with drug resistance [2,12]. According to published data [14 16], LAM family strains are also prevalent in some regions of Russia, and are also associated with drug resistance. It is interesting that members of two of the principal genetic groups (Beijing family, group 1; LAM family, group 2 [3]) of M. tuberculosis are highly prevalent in TB patients in the same regions of Russia. It has been suggested that the prevalence of Beijing family strains is a result of the ability of these strains to overcome the protective effects of vaccination of the population with bacille Calmette-Guérin [22]. A similar explanation may apply to the LAM family strains, which occur at a high frequency in the Russian population, which has a high rate of bacille Calmette-Guérin vaccination. As has been observed previously for isolates in Russia, mutations in codon 315 of the katg gene are found in the vast majority of isoniazid-resistant isolates [16,18]. However, the frequency of codon 315 mutations in isoniazid-resistant isolates in other populations has been reported to range from 35% to 97% [7]. Mutations in codon 315 do not significantly decrease the peroxidase activity of the katg gene product, but do decrease its ability to activate isoniazid [23]. These features allow the mutants to maintain the peroxidase activity required for virulence, and to resist killing by isoniazid. Such isolates often display resistance to only lower levels of isoniazid, and resistance to higher levels appears to correlate with loss of catalase activity or acquisition of mutations in multiple genes implicated in isoniazid resistance, e.g., inha or ahpc [4,5]. However, in the present study, resistance of the isolates carrying the codon 315 mutations to a high concentration of isoniazid (25 mg L) did not correlate with the presence of mutations in either the inha or ahpc genes. The striking difference between the frequencies of various mutations in the rpsl and rrs genes of streptomycin-resistant isolates (Fig. 2) was unexpected. As only isolates with different IS6110 RFLP profiles were selected for PCR sequencing, this dissimilarity cannot be explained by the existence of multiple isolates of the same strain. High-level streptomycin resistance has been correlated previously [4] with acquisition of the rpsl codon 43AAG fi AGG mutation, while low-level streptomycin resistance was correlated with changes in the rrs gene, as was observed in the present study for the Beijing family isolates. The correlation of the rrs 513A fi C mutation with high-level streptomycin resistance in the LAM family isolates is unusual. The molecular basis for this difference is unknown. The frequencies of mutations in rpob codons 516 (5.4%), 526 (15%) and 531 (71%) of the Beijing family isolates are similar to those reported for isolates in the north-west region of Russia [13] and the Archangel region [17]. The mutation 531TTG in rpob is the most commonly observed mutation in rifampicin-resistant isolates in many parts of the world, e.g., in Brazil (54%) [24], the USA (35%) [25], India (38.7%) [26], Germany (65%) [27] and Australia (52%) [28]. The
6 Lipin et al. TB drug resistance mutations and spoligotypes 625 predominance of mutations in rpob codon 531 of the rifampicin-resistant isolates belonging to the Beijing family is in good agreement with frequencies of mutations in codons of the rpob gene and rates of growth of spontaneous rifampicin-resistant mutants of M. tuberculosis strain H37Rv [29], and Mycobacterium leprae, Mycobacterium africanum and Mycobacterium avium strains [30]. Thus, the predominance of mutations in rpob codon 516 of the rifampicin-resistant isolates of the LAM family is unusual. Interestingly, mutations in codon 516 of the rpob gene confer a low level of crossresistance to rifabutin and KRM-1648 [30,31]. As different mutations in the rpob gene were detected in the same IS6110 RFLP cluster, the rpob gene mutations appear to have been acquired independently in most isolates during the course of chemotherapy. As such, differences in the frequencies of mutations in the 516, 526 and 531 codons of the rpob gene among isolates of the Beijing, Haarlem and LAM families may primarily reflect differences in mutational frequencies or the relative fitness of the mutations in the strain families, as opposed to a possible sampling bias caused by extensive transmission of individual MDR strains. The finding that eight (3.7%) of the 217 MDR isolates did not contain mutations in the sequenced regions of the katg and rpob genes was initially surprising. Given the observed frequencies of mutations in the sequenced regions of the katg gene in isoniazid-resistant isolates (95%) and in the sequenced regions of the rpob gene of rifampicin-resistant isolates (92%), fewer than two such isolates would be expected in a sample of 217 isolates if acquisition of isoniazid and rifampicin resistances was independent. However, seven of these eight isolates were members of the Haarlem family and, in this family, only 57% (12 of 21) of isoniazid-resistant isolates had mutations in the sequenced regions of the katg gene, and 52% (11 of 21) of rifampicin-resistant isolates had mutations in the RRDR of the rpob gene. Thus, the number of observed isolates without mutations is consistent with the independent frequencies of mutations in the individual genes in isolates of the Haarlem family. The low frequency of mutations revealed in the katg and rpob genes of MDR Haarlem isolates does not correspond with data concerning 21 MDR Haarlem isolates in Tunisia [32]. However, that study involved a clonal outbreak of an MDR Haarlem strain, confirmed by IS6110 RFLP typing [32], whereas the present study analysed the data for 19 isolates with different IS6110 RFLP profiles. Overall, the data indicate that the frequencies of individual mutations in the genes associated with rifampicin and streptomycin resistance vary dramatically among isolates belonging to different genotype families. Such variation may influence the performance of molecular diagnostic tests designed to detect mutations associated with drug resistance in M. tuberculosis isolates. This emphasises the importance of validating the performance of a diagnostic test in the population being tested. The biological significance of the predominance of certain mutations in particular genotype families remains to be determined. ACKNOWLEDGEMENTS This work was supported by funds from the International Science and Technology Center (ISTC) and the Biotechnology Engagement Program of the US Department of Health and Human Services (grant ISTC2628 BTEP63) and the CDC. Use of trade names is for identification only and does not constitute endorsement by the US Department of Health and Human Services, the Public Health Services or the CDC. We are grateful to O. Korobova and I. Ivanov for technical assistance. REFERENCES 1. Dye C, Espinal MA, Watt JC et al. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2001; 185: Anonymous. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 2006; 12: Sreevatsan S, Pan X, Stockbauer KE et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionary recent global dissemination. Proc Natl Acad Sci USA 1997; 94: Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: update. Tuberc Lung Dis 1998; 79: Ramaswamy SV, Reich R, Dou SJ et al. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003; 47: Herrera L, Jiménez S, Valverde A et al. Molecular analysis of rifampin-resistant Mycobacterium tuberculosis isolated in Spain ( ). Description of new mutations in the rpob gene and review of the literature. Int J Antimicrob Agents 2003; 21: Zhang M, Yue J, Yang Y-P et al. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J Clin Microbiol 2005; 43:
7 626 Clinical Microbiology and Infection, Volume 13 Number 6, June Kamerbeek J, Schouls L, Kolk A et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: Van Embden JDA, Cave MD, Crawford JT et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: Supply P, Mazars E, Lesjean S et al. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol 2000; 36: Filliol I, Driscoll JR, van Soolingen D et al. Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg Infect Dis 2002; 8: Glynn JR, Whiteley J, Bifani PJ et al. Worldwide occurrence of Beijing W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002; 8: Mokrousov I, Filliol I, Legrand E et al. Molecular characterization of multiple-drug-resistant Mycobacterium tuberculosis strains from northwestern Russia and analysis of rifampin resistance using RNA RNA mismatch analysis as compared to the line probe assay and sequencing of the rpob gene. Res Microbiol 2002; 153: Shemyakin IG, Stepanshina VN, Ivanov IY et al. Characterization of Mycobacterium tuberculosis clinical strains by molecular-biology methods. J Mol Gen Microbiol Virol (Russia) 2003; 1: Shemyakin IG, Stepanshina VN, Korobova OV et al. Genetic typing of Mycobacterium tuberculosis strains by spoligotyping and genome fingerprinting techniques. J Microbiol Epidemiol Immunol (Russia) 2002; 6: Shemyakin IG, Stepanshina VN, Ivanov IY et al. Characterization of drug-resistant clinical isolates of Mycobacterium tuberculosis derived from Russian inmates. Int J Tuberc Lung Dis 2004; 8: Toungoussova OS, Sandven P, Mariandyshev AO et al. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol 2002; 40: Mokrousov I, Narvskaya O, Otten T et al. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, Antimicrob Agents Chemother 2002; 46: Canetti G, Fox W, Khomenko A et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull WHO 1969; 41: Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: van Doorn HR, Kuijper EJ, van der Ende A et al. The susceptibility of Mycobacterium tuberculosis to isoniazid and the ArgLeu mutation at codon 463 of katg are not associated. J Clin Microbiol 2001; 39: Cohn DL, O Brien RJ. The use of restriction fragment length polymorphism (RFLP) analysis for epidemiological studies of tuberculosis in developing countries. Int J Tuberc Lung Dis 1997; 2: Wengenack NL, Uhl JR, Amand ALS et al. Recombinant Mycobacterium tuberculosis KatG (S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. J Infect Dis 1997; 176: Valim ARM, Rossetti MLR, Ribeiro MO, Zaha A. Mutations in the rpob gene of multidrug-resistant Mycobacterium tuberculosis strains from Brazil. J Clin Microbiol 2000; 38: Gingeras TR, Ghandour G, Wang E et al. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res 1998; 8: Siddiqi N, Shamim M, Hussain S et al. Molecular characterization of multidrug-resistant strains of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 2002; 46: Heep M, Brandstatter B, Rieger U et al. Frequency of rpob mutations inside and outside the cluster I region in rifampin-resistant Mycobacterium tuberculosis clinical strains. J Clin Microbiol 2001; 39: Yuen LKW, LeslieD, ColoePJ. Bacteriological andmolecular analysis of rifampin-resistant Mycobacterium tuberculosis strains in Australia. J Clin Microbiol 1999; 37: Billington OJ, McHugh TD, Gillespie SH. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1999; 43: Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995; 8: Williams DL, Spring L, Collins L et al. Contribution of rpob mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 1998; 42: Mardassi H, Namouchi A, Haltiti R et al. Tuberculosis due to resistant Haarlem strain, Tunisia. Emerg Infect Dis 2005; 11:
Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa
Journal of Antimicrobial Chemotherapy Advance Access published October 21, 2008 Journal of Antimicrobial Chemotherapy doi:10.1093/jac/dkn433 Rapid genotypic assays to identify drug-resistant Mycobacterium
More informationTransmissibility, virulence and fitness of resistant strains of M. tuberculosis. CHIANG Chen-Yuan MD, MPH, DrPhilos
Transmissibility, virulence and fitness of resistant strains of M. tuberculosis CHIANG Chen-Yuan MD, MPH, DrPhilos Transmissibility, Virulence and Fitness of resistant strains of M. tuberculosis For infectious
More informationA simple, rapid and economic method for detecting multidrug-resistant tuberculosis
braz j infect dis. 2013;17(6):667 671 The Brazilian Journal of INFECTIOUS DISEASES www.elsevier.com/locate/bjid Original article A simple, rapid and economic method for detecting multidrug-resistant tuberculosis
More informationPrevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012
Yin et al. BMC Microbiology (2016) 16:85 DOI 10.1186/s12866-016-0699-2 RESEARCH ARTICLE Open Access Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China:
More informationMycobacterium tuberculosis and Molecular Epidemiology: An Overview
Journal of Microbiology Research 2014, 4(6A): 25-31 DOI: 10.5923/s.microbiology.201401.04 Mycobacterium tuberculosis and Molecular Epidemiology: An Overview Asho Ali Department of Biology, King Abdul Aziz
More informationA Rapid and Sensitive Chip-based Assay for Detection of rpob Gene Mutations Conferring Rifampicin Resistance in Mycobacterium tuberculosis (TB).
A Rapid and Sensitive Chip-based Assay for Detection of rpob Gene Mutations Conferring Rifampicin Resistance in Mycobacterium tuberculosis (TB). Wanyuan Ao, Steve Aldous, Evelyn Woodruff, Brian Hicke,
More informationORIGINAL ARTICLE /j x
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01495.x Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katg: a decade of experience
More informationHigh Incidence of the Beijing Genotype among Multidrug-Resistant Isolates of Mycobacterium tuberculosis in a Tertiary Care Center in Mumbai, India
BRIEF REPORT High Incidence of the Beijing Genotype among Multidrug-Resistant Isolates of Mycobacterium tuberculosis in a Tertiary Care Center in Mumbai, India Deepak Almeida, 1 Camilla Rodrigues, 2 Tester
More informationMolecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis.
Title Molecular tests for rapid detection of rifampicin and isoniazid resistance in Mycobacterium. Author(s) Ho, PL; Yam, WC; Leung, CC; Yew, WW; Mok, TYW; Chan, KS; Tam, CM Citation Hong Kong Medical
More informationDRUG RESISTANCE IN TUBERCULOSIS
DRUG RESISTANCE IN TUBERCULOSIS INTRODUCTION Up to 50 million people may be infected with drug-resistant resistant TB.* Hot zones of MDR-TB such as Russia, Latvia, Estonia, Argentina and the Dominican
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationResearch Article Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant Tuberculosis in Nepal
Hindawi International Scholarly Research Notices Volume 2017, Article ID 1635780, 5 pages https://doi.org/10.1155/2017/1635780 Research Article Use of Genotype MTBDRplus Assay for Diagnosis of Multidrug-Resistant
More informationDepartment of Microbiology, Faculty of Medicine, Kuwait University, Kuwait
Indian J Med Res 135, May 2012, pp 756-762 Variations in the occurrence of specific rpob mutations in rifampicinresistant Mycobacterium tuberculosis isolates from patients of different ethnic groups in
More informationJillian Dormandy, BS; Akos Somoskovi, MD, PhD; Barry N. Kreiswirth, PhD; Jeffrey R. Driscoll, PhD; David Ashkin, MD; and Max Salfinger, MD
Original Research LUNG INFECTION Discrepant Results Between Pyrazinamide Susceptibility Testing by the Reference BACTEC 460TB Method and pnca DNA Sequencing in Patients Infected With Multidrug-Resistant
More informationA ten-year evolution of a multidrugresistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia ( )
A ten-year evolution of a multidrugresistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011) Naira Dekhil 1, Besma Mhenni 1, Raja Haltiti 2, and Helmi Mardassi 1 (speaker)
More informationGlobal epidemiology of drug-resistant tuberculosis. Factors contributing to the epidemic of MDR/XDR-TB. CHIANG Chen-Yuan MD, MPH, DrPhilos
Global epidemiology of drug-resistant tuberculosis Factors contributing to the epidemic of MDR/XDR-TB CHIANG Chen-Yuan MD, MPH, DrPhilos By the end of this presentation, participants would be able to describe
More informationRapid detection of mutations in rpob gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay
Indian J Med Res 117, February 2003, pp 76-80 Rapid detection of mutations in rpob gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay Meera Sharma, Sunil Sethi, Baijayantimala
More informationMulti-drug Resistant Tuberculosis in Rajshahi District
TAJ December 2005; Volume 18 Number 2 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Original Article Multi-drug Resistant Tuberculosis in Rajshahi District M Wasim Hussain, 1 M Azizul
More informationDiagnosis of drug resistant TB
Diagnosis of drug resistant TB Megan Murray, MD, ScD Harvard School of Public Health Brigham and Women s Hospital Harvard Medical School Broad Institute Global burden of TB 9 million new cases year 2 million
More informationRapid Diagnosis and Detection of Drug Resistance in Tuberculosis
Rapid Diagnosis and Detection of Drug Resistance in Tuberculosis YAM Wing-Cheong 任永昌 Department of Microbiology The University of Hong Kong Tuberculosis Re-emerging problem in industrialized countries
More informationCharacterization of Mutations in the Rpob and Katg Gene of Mycobacterium Tuberculosis Isolates From Pasteur Institute of Tehran
2461 Int. J. Adv. Biol. Biom. Res, 2014; 2 (8), 2461-2465 IJABBR- 2014- eissn: 2322-4827 International Journal of Advanced Biological and Biomedical Research Journal homepage: www.ijabbr.com Original Article
More informationPrevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients
Journal of Infection (2006) 53, 331e336 www.elsevierhealth.com/journals/jinf Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients Parissa
More informationRapid Diagnosis of Extensively Drug-Resistant Tuberculosis by Use of a Reverse Line Blot Hybridization Assay
JOURNAL OF CLINICAL MICROBIOLOGY, July 2011, p. 2546 2551 Vol. 49, No. 7 0095-1137/11/$12.00 doi:10.1128/jcm.02511-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Rapid Diagnosis
More informationGenetic Polymorphism at Codon 463 in the katg Gene in Isoniazid-Sensitive and -Resistant Isolates of Mycobacterium tuberculosis from the Middle East
Original Paper Med Principles Pract 2001;10:129 134 Received: January 31, 2001 Revised: May 14, 2001 Genetic Polymorphism at Codon 463 in the katg Gene in Isoniazid-Sensitive and -Resistant Isolates of
More informationExtremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study
Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study J. Mäkinen, M. Marjamäki, M. Haanperä-Heikkinen, H. Marttila, L. B. Endourova, S. E. Presnova,
More informationMolecular Methods in the Diagnosis of Drug Resistant Tuberculosis. Dr Sahajal Dhooria
Molecular Methods in the Diagnosis of Drug Resistant Tuberculosis Dr Sahajal Dhooria What is drug resistant TB? Definitions MDR TB defined as resistance to isoniazid and rifampicin, with or without resistance
More informationThe nature and consequence of genetic variability within Mycobacterium tuberculosis
The nature and consequence of genetic variability within Mycobacterium tuberculosis M. Kato-Maeda, 1 P.J. Bifani, 2 B.N. Kreiswirth, 2 and P.M. Small 1 1 Divisions of Infectious Diseases and Geographic
More informationA. Nusrath Unissa, N. Selvakumar, Sujatha Narayanan, C. Suganthi, and L. E. Hanna
Hindawi Publishing Corporation BioMed Research International Volume 2015, Article ID 257983, 5 pages http://dx.doi.org/10.1155/2015/257983 Research Article Investigation of Ser315 Substitutions within
More informationThe Efficacy of Genotype MTBDRplus Assay in Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates
The Efficacy of Genotype MTBDRplus Assay in Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis Complex Isolates Singh Shruti S 1, Desai Pratibha B. 2 1,2 Department of
More informationPATTERNS OF DRUG RESISTANCE AND RFLP ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED FROM RECURRENT TUBERCULOSIS PATIENTS IN SRI LANKA
PATTERNS OF DRUG RESISTANCE AND RFLP ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED FROM RECURRENT TUBERCULOSIS PATIENTS IN SRI LANKA DN Magana-Arachchi 1, AJ Perera 1, V Senaratne 2 and NV Chandrasekharan
More informationMULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic
MULTIDRUG- RESISTANT TUBERCULOSIS Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic I have no relevant financial relationships. Discussion includes off label use of: amikacin
More informationMolecular Epidemiology of Tuberculosis. Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis
Molecular Epidemiology of Tuberculosis Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis Overview TB transmission and pathogenesis Genotyping methods Genotyping for clinical management
More informationMultidrug resistance (MDR) epitomises. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan
Eur Respir J 2009; 33: 368 374 DOI: 10.1183/09031936.00089808 CopyrightßERS Journals Ltd 2009 Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan
More informationThe Molecular Epidemiology of Tuberculosis
The Molecular Epidemiology of Tuberculosis Barry N. Kreiswirth,, PhD Director, PHRI TB Center Airborne pathogen, Mycobacterium tuberculosis Slow grower; doubles 24hrs; 3-4 weeks to culture 3-4 weeks for
More informationTuberculosis Transmission by Patients with Smear- Negative Pulmonary Tuberculosis in a Large Cohort in The Netherlands
MAJOR ARTICLE Tuberculosis Transmission by Patients with Smear- Negative Pulmonary Tuberculosis in a Large Cohort in The Netherlands Alma Tostmann, 1,2 Sandra V. Kik, 3,4 Nico A. Kalisvaart, 3 Maruschka
More informationRapid detection of multidrug-resistant tuberculosis
Eur Respir J 1997; 10: 1120 1124 DOI: 10.1183/09031936.97.10051120 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 0903-1936 Rapid detection of multidrug-resistant
More informationHow Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008
How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008 Today s Outline 1) Global spread of Mtb Comparative genomics Phylogeny 2) Transmission of drug-resistant Mtb Fitness assays Molecular epidemiology
More informationCDC s Approach to Fast Track Laboratory Diagnosis for Persons at Risk of Drug Resistant TB: Molecular Detection of Drug Resistance (MDDR) Service
CDC s Approach to Fast Track Laboratory Diagnosis for Persons at Risk of Drug Resistant TB: Molecular Detection of Drug Resistance (MDDR) Service Beverly Metchock, DrPH, D(ABMM) Team Lead, Reference Laboratory
More informationMolecular Characterization of Mycobacterium tuberculosis H37Rv/Ra Variants: Distinguishing the Mycobacterial Laboratory Strain
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2000, p. 3200 3204 Vol. 38, No. 9 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Molecular Characterization of Mycobacterium
More informationIgor Mokrousov, 1 * Olga Narvskaya, 1 Tatiana Otten, 2 Elena Limeschenko, 1 Lidia Steklova, 3 and Boris Vyshnevskiy 2
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2002, p. 1417 1424 Vol. 46, No. 5 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.5.1417 1424.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationMicrobiological Pathology, Sefako Makgatho Health Science University, Pretoria, South Africa 2
The Incidence of discordant Rifampicin susceptibility results between genotypic and phenotypic methods in Mycobacterium tuberculosis complex isolates at Dr George Mukhari Hospital Tertiary Laboratory,
More informationTB 101 Disease, Clinical Assessment and Lab Testing
TB 101 Disease, Clinical Assessment and Lab Testing Pacific Islands Tuberculosis Controllers Association Conference (PITCA) Clinical Laboratory Breakout None Disclosure Objectives Be able to list and explain
More informationGlobal Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics
Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics Neel R. Gandhi, MD Emory Rollins School of Public Health January 17, 2013 Medical Research Council BMJ 1948
More informationTransmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis
Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis Sofía Samper, Carlos Martín, Alfonso Pinedo*, Antonio Rivero, Jesús Blázquez, Fernando Baquero,
More informationMIRU-VNTR.. (HGI) HunterGaston Discriminatory Index MIRU-VNTR :
- ( ) MIRU- *. :. 12 MIRU- 15 MIRU-. MIRU-. (HGI) HunterGaston Discriminatory Index.( ) : MIRU- QUB11b.(HGI=) QUB26 (HGI /) QUB26. MIRU16. MIRU26 MIRU23 MIRU27 MIRU39 Mtub21.(HGI
More informationGenotyping of Multidrug-Resistant Strains of Mycobacterium tuberculosis in the Limpopo Province. Kgasha Matete Olga
Genotyping of Multidrug-Resistant Strains of Mycobacterium tuberculosis in the Limpopo Province by Kgasha Matete Olga DISSERTATION Submitted in fulfillment of the requirements for the degree of MASTER
More informationTuberculosis Disparity Between US-born African-Americans and Caucasians in Houston:
Tuberculosis Disparity Between US-born African-Americans and Caucasians in Houston: A population-based study Jose A. Serpa 1, M.D.; Larry D. Teeter 2, Ph.D., James M. Musser 2, M.D., Ph.D. and Edward A.
More informationMultidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment
Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment L. P. Ormerod Chest Clinic, Blackburn Royal Infirmary, Blackburn, Lancs BB2 3LR, and Postgraduate School of Medicine and
More informationPatterns of rpoc Mutations in Drug-Resistant Mycobacterium tuberculosis Isolated from Patients in South Korea
ORIGINAL ARTICLE https://doi.org/10.4046/trd.2017.0042 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2018;81:222-227 Patterns of rpoc Mutations in -Resistant Mycobacterium tuberculosis Isolated
More informationPrimary Multi Drug Resistance in New Pulmonary Tuberculosis Patients in Western Uttar Pradesh, India
ISSN: 2319-7706 Volume 4 Number 8 (2015) pp. 656-663 http://www.ijcmas.com Original Research Article Primary Multi Drug Resistance in New Pulmonary Tuberculosis Patients in Western Uttar Pradesh, India
More informationWhite Paper Application
White Paper Application Project Title: Whole genome sequencing of clinical strains of Mycobacterium tuberculosis Authors: David Alland, Jerrold Ellner, Susan Dorman, Moses Joloba, Clifton Barry Primary
More informationDRUG-SENSITIVE AND RESIStant
ORIGINAL CONTRIBUTION Drug-Resistant Tuberculosis, Clinical Virulence, and the Dominance of the Beijing Strain Family in Russia Francis Drobniewski, MD, PhD Yanina Balabanova, MD, PhD Vladyslav Nikolayevsky,
More informationResearch Article Discrepancies in Drug Susceptibility Test for Tuberculosis Patients Resulted from the Mixed Infection and the Testing System
BioMed Research International Volume 2015, Article ID 651980, 7 pages http://dx.doi.org/10.1155/2015/651980 Research Article Discrepancies in Drug Susceptibility Test for Tuberculosis Patients Resulted
More informationRapid differentiation of mycobacterium tuberculosis and mycobacterium leprae from sputum by polymerase chain reaction
Original Article Nepal Medical College Journal 27; 9(1): Rapid differentiation of mycobacterium tuberculosis and mycobacterium leprae from sputum by polymerase chain reaction Bishwa Raj Sapkota, Chaman
More informationMIRU-VNTR typing of drug-resistant tuberculosis isolates in Greece
Therapeutic Advances in Respiratory Disease Original Research MIRU-VNTR typing of drug-resistant tuberculosis isolates in Greece Nikoletta Rovina, Simona Karabela, Pantelis Constantoulakis, Vassiliki Michou,
More informationPlinke, C; Cox, H S; Zarkua, N; Karimovich, H A; Braker, K; Diel, R; Rüsch-Gerdes, S; Feuerriegel, S; Niemann, S
MSF Field earch embcab Sequence Variation Among Ethambutol-istant Mycobacterium Tuberculosis Isolates Without embb306 Mutation Item type Authors Article Plinke, C; Cox, H S; Zarkua, N; Karimovich, H A;
More informationMolecular diagnosis of MDR-TB using GenoType MTBDRplus 96 assay in Ibadan, Nigeria
Niger. J. Physiol. Sci. 28(December 2013) 187 191 www.njps.com.ng Molecular diagnosis of MDR-TB using GenoType MTBDRplus 96 assay in Ibadan, Nigeria * 1 Kehinde A.O. and 2 Adebiyi, E.O. Department of Medical
More informationCBNAAT: A Novel Tool for Rapid Detection of MTB and Rifampicin Resistance
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 12 (2016) pp. 383-388 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.512.042
More informationTitle: Chest wall abscess due to Mycobacterium bovis BCG after intravesical BCG therapy
JCM Accepts, published online ahead of print on 23 November 2011 J. Clin. Microbiol. doi:10.1128/jcm.05888-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationReceived 4 June 2013; Final revision 1 August 2013; Accepted 30 August 2013; first published online 27 September 2013
Epidemiol. Infect. (2014), 142, 1328 1333. Cambridge University Press 2013 doi:10.1017/s0950268813002409 SHORT REPORT Characterization of multi-drug resistant Mycobacterium tuberculosis from immigrants
More informationAt Baltic crossroads: a molecular snapshot of Mycobacterium tuberculosis population diversity in Kaliningrad, Russia
RESEARCH ARTICLE At Baltic crossroads: a molecular snapshot of Mycobacterium tuberculosis population diversity in Kaliningrad, Russia Igor Mokrousov 1,2, Tatiana Otten 3, Thierry Zozio 2, Eugeni Turkin
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Sherman SI, Wirth LJ, Droz J-P, et al. Motesanib diphosphate
More informationGenotypic diversity of Mycobacterium tuberculosis in Pretoria
Genotypic diversity of Mycobacterium tuberculosis in Pretoria P Hove, J Molepo, S Dube, M Nchabeleng Prisca Hove, HBMLS, MSc(Med)Micro, Postgraduate Student Julitha Molepo, NDMedTech, BSc (Hons), MSc,
More informationKen Jost, BA, has the following disclosures to make:
Diagnosis of TB Disease: Laboratory Ken Jost, BA May 10, 2017 TB Intensive May 9-12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Ken Jost, BA, has the following disclosures to make: No conflict
More informationDrug Resistant Tuberculosis Biology, Epidemiology and Control Dr. Christopher Dye
Director of Health Information World Health Organization Geneva 1 1. Why TB patients are treated with drugs 2 Natural history and control of TB Fast 5/1 Slow 5/1 Uninfected Latent Active 1 1 infection/case
More informationRapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array
ORIGINAL ARTICLE BACTERIOLOGY Rapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide array W.-L. Huang 1, Z.-J. Hsu 1, T. C. Chang 2 and R.
More informationMolecular Typing of Mycobacterium tuberculosis Based on Variable Number of Tandem DNA Repeats Used Alone and in Association with Spoligotyping
JOURNAL OF CLINICAL MICROBIOLOGY, July 2000, p. 2520 2524 Vol. 38, No. 7 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Molecular Typing of Mycobacterium
More informationGlobal TB Burden, 2016 estimates
TUBERCULOSIS EPIDEMIOLOGY LOCAL, STATE, NATIONAL, GLOBAL Office of Communicable Disease Epidemiology Global TB Burden, 216 estimates Total TB Estimated number of TB cases 1.4 million 14 per 1, Estimated
More informationReceived 26 October 2006/Returned for modification 5 February 2007/Accepted 6 March 2007
JOURNAL OF CLINICAL MICROBIOLOGY, May 2007, p. 1483 1490 Vol. 45, No. 5 0095-1137/07/$08.00 0 doi:10.1128/jcm.02191-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. A Recently
More informationThe Gene Mutation and Drug Resistant of Mycobacterium tuberculosis in Patients of Chongqing
Research Article The Gene Mutation and Drug Resistant of Mycobacterium tuberculosis in Patients of Chongqing Yishu Tang *, Peiyang Song, Huiting Su Department of Laboratory Medicine, The First Affiliated
More informationTable S1. Primers and PCR protocols for mutation screening of MN1, NF2, KREMEN1 and ZNRF3.
Table S1. Primers and PCR protocols for mutation screening of MN1, NF2, KREMEN1 and ZNRF3. MN1 (Accession No. NM_002430) MN1-1514F 5 -GGCTGTCATGCCCTATTGAT Exon 1 MN1-1882R 5 -CTGGTGGGGATGATGACTTC Exon
More informationTuberculosis transmission in the Netherlands : the role of immigration and travel Kik, S.V.
UvA-DARE (Digital Academic Repository) Tuberculosis transmission in the Netherlands : the role of immigration and travel Kik, S.V. Link to publication Citation for published version (APA): Kik, S. V. (2009).
More informationFrances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS
The Laboratory s Role in Caring for Patients Diagnosed with TB Frances Morgan, PhD October 21, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE
More informationThe New England Journal of Medicine EXOGENOUS REINFECTION AS A CAUSE OF RECURRENT TUBERCULOSIS AFTER CURATIVE TREATMENT
EXOGENOUS REINFECTION AS A CAUSE OF RECURRENT TUBERCULOSIS AFTER CURATIVE TREATMENT ANNELIES VAN RIE, M.D., ROBIN WARREN, PH.D., MADELEINE RICHARDSON, M.SC., THOMAS C. VICTOR, PH.D., ROBERT P. GIE, M.D.,
More informationScott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer
Tuberculosis in the 21 st Century Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer Feedback Poll In my opinion, the recent media coverage of
More informationkatg Gene as a Surrogate Molecular Marker Leading to Cause Drug Resistance in Mycobacterium tuberculosis Isolates
American Journal of Infectious Diseases and Microbiology, 2013, Vol. 1, No. 5, 86-91 Available online at http://pubs.sciepub.com/ajidm/1/5/2 Science and Education Publishing DOI:10.12691/ajidm-1-5-2 katg
More informationTreatment of Active Tuberculosis
Treatment of Active Tuberculosis Jeremy Clain, MD Pulmonary & Critical Care Medicine Mayo Clinic October 16, 2017 2014 MFMER slide-1 Disclosures No relevant financial relationships No conflicts of interest
More informationMultiplex PCR for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Isolated from Bandung, Indonesia
MICOBIOLOGY INDONESIA, December 007, p 4 Volume, Number 3 ISSN 973477 Multiplex PC for apid Detection of ifampin and Isoniazid esistance in Mycobacterium tuberculosis Isolated from Bandung, Indonesia HEA
More informationAugust 30, 1991 / 40(34);
August 30, 1991 / 40(34);585-591 Epidemiologic Notes and Reports Nosocomial Transmission of Multidrug-Resistant Tuberculosis Among HIV-Infected Persons -- Florida and New York, 1988-1991 During 1990 and
More informationTB Updates for the Physician Rochester, Minnesota June 19, 2009
TB Updates for the Physician Rochester, Minnesota June 19, 2009 Mycobacterial Laboratory Science Update Nancy L. Wengenack, Ph.D. Associate Professor of Laboratory Medicine and Pathology Division of Clinical
More informationMolecular Characterization of Isoniazid-Resistant Mycobacterium tuberculosis Isolates Collected in Australia
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2005, p. 4068 4074 Vol. 49, No. 10 0066-4804/05/$08.00 0 doi:10.1128/aac.49.10.4068 4074.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.
More informationOptimal Combination of VNTR Typing for Discrimination of Isolated Mycobacterium tuberculosis in Korea
ORIGINAL ARTICLE http://dx.doi.org/10.4046/trd.2014.76.2.59 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2014;76:59-65 Optimal Combination of VNTR Typing for Discrimination of Isolated Mycobacterium
More informationMutations Prevalent among Rifampin- and Isoniazid-Resistant Mycobacterium tuberculosis Isolates from a Hospital in Vietnam
JOURNAL OF CLINICAL MICROBIOLOGY, July 2006, p. 2333 2337 Vol. 44, No. 7 0095-1137/06/$08.00 0 doi:10.1128/jcm.00330-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Mutations
More informationReceived 6 November 1996/Accepted 28 February 1997
JOURNAL OF CLINICAL MICROBIOLOGY, June 1997, p. 1390 1393 Vol. 35, No. 6 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Genetic Characterization of Multidrug-Resistant Mycobacterium
More informationDrug-Susceptible Mycobacterium tuberculosis Beijing Genotype Does Not Develop Mutation-Conferred Resistance to Rifampin at an Elevated Rate
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2003, p. 1520 1524 Vol. 41, No. 4 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.4.1520 1524.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationDrug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER
Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER Outline Drug resistant TB: definitions and epidemiology How does TB become resistant? Current drug susceptibility
More informationSupplementary Document
Supplementary Document 1. Supplementary Table legends 2. Supplementary Figure legends 3. Supplementary Tables 4. Supplementary Figures 5. Supplementary References 1. Supplementary Table legends Suppl.
More informationWei-Lun Huang,* Ting-Lin Chi, Mei-Hua Wu, and Ruwen Jou*
JOURNAL OF CLINICAL MICROBIOLOGY, July 2011, p. 2502 2508 Vol. 49, No. 7 0095-1137/11/$12.00 doi:10.1128/jcm.00197-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Performance
More informationCulture Density (OD600) 0.1. Culture Density (OD600) Culture Density (OD600) Culture Density (OD600) Culture Density (OD600)
A. B. C. D. E. PA JSRI JSRI 2 PA DSAM DSAM 2 DSAM 3 PA LNAP LNAP 2 LNAP 3 PAO Fcor Fcor 2 Fcor 3 PAO Wtho Wtho 2 Wtho 3 Wtho 4 DTSB Low Iron 2 4 6 8 2 4 6 8 2 22 DTSB Low Iron 2 4 6 8 2 4 6 8 2 22 DTSB
More informationTB trends and TB genotyping
Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures
More informationVNTR . VNTR. VNTR. (Original Article) PCR-RFLP ( ETR-B, ETR-C, ETR-D, ETR-E, ETR-F : 7 .VNTR : : (Atypical Mycobacteria)
90 11 3 (Original Article) 4 3 2 1 1. 2. 3. 4. (Non- Tuberculosis Mycobacterium, NTM) :.. (Variable Number Tandem Repeat, VNTR). VNTR ) 48 : PCR-RFLP ( MPTR-A, ETR-A, ETR-B, ETR-C, ETR-D, ETR-E, ETR-F
More informationThe authors assessed drug susceptibility patterns
Drug Resistance Among Tuberculosis Patients, 1991 and 1992 New York City, CYNTHIA R. DRIVER, RN, MPH THOMAS R. FRIEDEN, MD, MPH ALAN B. BLOCH, MD, MPH IDA M. ONORATO, MD All the authors are with the Division
More informationCharacterization of Mycobacterium tuberculosis Isolates from Patients in Houston, Texas, by Spoligotyping
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2000, p. 669 676 Vol. 38, No. 2 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Characterization of Mycobacterium tuberculosis
More informationDiagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013
TB Nurse Case Management San Antonio, Texas April 9-11, 2013 Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013 Ken Jost has the following disclosures to make: No conflict of interests No relevant
More informationNAAT in the Clinical Laboratory and Impact on Infection Control 9 th National Conference on Laboratory Aspects of Tuberculosis APHL
NAAT in the Clinical Laboratory and Impact on Infection Control 9 th National Conference on Laboratory Aspects of Tuberculosis APHL Susan Novak-Weekley, S(M), ASCP, Ph.D., D(ABMM) Director of Microbiology,
More informationMIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex
MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex Marie Claire Rowlinson, PhD D(ABMM) Florida Bureau of Public Health Laboratories
More informationIsoniazid MIC and KatG Gene Mutations among Mycobacterium tuberculosis Isolates in Northwest of Iran
Iranian Journal of Basic Medical Sciences Vol. 14, No. 6, Nov-Dec 2011, 540-545 Received: Mar 5, 2011; Accepted: Jun 20, 2011 Original article Isoniazid MIC and KatG Gene Mutations among Mycobacterium
More informationTUBERCULOSIS TREATMENT WITH MOBILE-PHONE MEDICATION REMINDERS IN NORTHERN THAILAND
Southeast Asian J Trop Med Public Health TUBERCULOSIS TREATMENT WITH MOBILE-PHONE MEDICATION REMINDERS IN NORTHERN THAILAND Piyada Kunawararak 1, Sathirakorn Pongpanich 2, Sakarin Chantawong 1, Pattana
More informationMolecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA January 2016 Summary This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis
More informationSputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation?
Journal of Antimicrobial Chemotherapy (27) 59, 794 798 doi:.93/jac/dkm25 Sputum conversion among patients with pulmonary tuberculosis: are there implications for removal of respiratory isolation? Jesús
More information